Literature DB >> 17371404

Apicomplexan UCHL3 retains dual specificity for ubiquitin and Nedd8 throughout evolution.

Eva-Maria Frickel1, Víctor Quesada, Larissa Muething, Marc-Jan Gubbels, Eric Spooner, Hidde Ploegh, Katerina Artavanis-Tsakonas.   

Abstract

Post-translational modification of proteins by ubiquitin or ubiquitin-like polypeptides such as Nedd8 controls cellular functions including protein degradation, the cell cycle and transcription. Here we have used an activity-based chemical probe that covalently labels ubiquitin hydrolases. We identify four such enzymes from Toxoplasma gondii by mass spectrometry. The homologue of mammalian UCHL3 was cloned from both T. gondii and Plasmodium falciparum and we show that both enzymes possess deubiquitinating as well as deNeddylating activity. A phylogenetic analysis of the UCHL3 amino acid sequences from several eukaryotes suggests that dual specificity for ubiquitin and Nedd8 was present in the ancestral eukaryotic UCHL3 and has been conserved throughout evolution. Finally, the structural characterization of UCHL3 from T. gondii shows a unique insertion at the surface of this enzyme, which may be involved in novel interactions with other proteins. The characterization of these apicomplexan UCHL3s adds to our understanding of the ubiquitin and Nedd8 pathways in these parasites.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17371404     DOI: 10.1111/j.1462-5822.2007.00896.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  41 in total

Review 1.  Chromatin-mediated epigenetic regulation in the malaria parasite Plasmodium falciparum.

Authors:  Liwang Cui; Jun Miao
Journal:  Eukaryot Cell       Date:  2010-05-07

Review 2.  Ubiquitin-like modifiers and their deconjugating enzymes in medically important parasitic protozoa.

Authors:  Elizabeth L Ponder; Matthew Bogyo
Journal:  Eukaryot Cell       Date:  2007-09-28

3.  Substrate filtering by the active site crossover loop in UCHL3 revealed by sortagging and gain-of-function mutations.

Authors:  Maximilian W Popp; Katerina Artavanis-Tsakonas; Hidde L Ploegh
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

Review 4.  Function and regulation of protein neddylation. 'Protein modifications: beyond the usual suspects' review series.

Authors:  Gwénaël Rabut; Matthias Peter
Journal:  EMBO Rep       Date:  2008-09-19       Impact factor: 8.807

5.  DENEDDYLASE1 deconjugates NEDD8 from non-cullin protein substrates in Arabidopsis thaliana.

Authors:  Julia Mergner; Stephanie Heinzlmeir; Bernhard Kuster; Claus Schwechheimer
Journal:  Plant Cell       Date:  2015-03-17       Impact factor: 11.277

6.  UCHL3 promotes pancreatic cancer progression and chemo-resistance through FOXM1 stabilization.

Authors:  Zhiwang Song; Junhe Li; Ling Zhang; Jun Deng; Ziling Fang; Xiaojun Xiang; Jianping Xiong
Journal:  Am J Cancer Res       Date:  2019-09-01       Impact factor: 6.166

7.  UCHL3 promotes aerobic glycolysis of pancreatic cancer through upregulating LDHA expression.

Authors:  Y Fan; D Hu; D Li; C Ma; Y Tang; Q Tao; L Deng; D Tang
Journal:  Clin Transl Oncol       Date:  2021-02-22       Impact factor: 3.405

Review 8.  Deubiquitinating enzymes as promising drug targets for infectious diseases.

Authors:  Bindu Nanduri; Akamol E Suvarnapunya; Malabi Venkatesan; Mariola J Edelmann
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

9.  Catch-and-release probes applied to semi-intact cells reveal ubiquitin-specific protease expression in Chlamydia trachomatis infection.

Authors:  Jasper H L Claessen; Martin D Witte; Nicholas C Yoder; Angela Y Zhu; Eric Spooner; Hidde L Ploegh
Journal:  Chembiochem       Date:  2013-01-18       Impact factor: 3.164

10.  The Ubiquitin Proteome of Toxoplasma gondii Reveals Roles for Protein Ubiquitination in Cell-Cycle Transitions.

Authors:  Natalie C Silmon de Monerri; Rama R Yakubu; Allan L Chen; Peter J Bradley; Edward Nieves; Louis M Weiss; Kami Kim
Journal:  Cell Host Microbe       Date:  2015-11-11       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.